Enanta Pharmaceuticals (ENTA) Ending Cash Balance (2012 - 2026)
Enanta Pharmaceuticals (ENTA) posted Ending Cash Balance of $36.78 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 23.7% from $48.17 million a year earlier and down 3.9% from the prior quarter.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Ending Cash Balance (2012 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Enanta Pharmaceuticals' Ending Cash Balance came in at $35.66 million, down 13.5% from FY2024.
- Annual Ending Cash Balance shows a five-year compound annual growth rate of -16.5% (FY2020 to FY2025).
- In prior fiscal years, Enanta Pharmaceuticals' Ending Cash Balance was $41.2 million in FY2024 (-53.9%), $89.36 million in FY2023 (+86.3%), $47.96 million in FY2022 (-17.0%) and $57.81 million in FY2021 (-34.1%).
- Quarterly Ending Cash Balance has run from a low of $32.34 million in fiscal Q3 2022 to a high of $99.68 million in fiscal Q1 2022 over five years.
- On a year-over-year basis, Ending Cash Balance has declined in each of the last four quarters, with an average decline of 8.5% over the last eight quarters.
- The strongest year-over-year quarter for Ending Cash Balance in the past five years was fiscal Q3 2022, with growth of 520.8%; the weakest was fiscal Q3 2024, with a decline of 59.9%.
- According to Business Quant data, Ending Cash Balance for the three prior fiscal quarters was $38.29 million (Q2 2026), $40.8 million (Q1 2026) and $35.66 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Enanta Pharmaceuticals | 326.73 Mn | -401.27 Mn | - | 36.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.78 Mn |
| Mar 31, 2026 | 38.29 Mn |
| Dec 31, 2025 | 40.80 Mn |
| Sep 30, 2025 | 35.66 Mn |
| Jun 30, 2025 | 48.17 Mn |
| Mar 31, 2025 | 63.57 Mn |
| Dec 31, 2024 | 88.32 Mn |
| Sep 30, 2024 | 41.20 Mn |
| Jun 30, 2024 | 39.74 Mn |
| Mar 31, 2024 | 67.51 Mn |
| Dec 31, 2023 | 43.90 Mn |
| Sep 30, 2023 | 89.36 Mn |
| Jun 30, 2023 | 99.15 Mn |
| Mar 31, 2023 | 77.15 Mn |
| Dec 31, 2022 | 46.19 Mn |
| Sep 30, 2022 | 47.96 Mn |
| Jun 30, 2022 | 32.34 Mn |
| Mar 31, 2022 | 41.60 Mn |
| Dec 31, 2021 | 99.68 Mn |
| Sep 30, 2021 | 57.81 Mn |
API Access
Enanta Pharmaceuticals Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();